Loading...
Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions
PAX5 encodes a master regulator of B-cell development. It fuses to other genes associated with acute lymphoblastoid leukemia (ALL). These fusion products are potent dominant-negative (DN) inhibitors of wild-type PAX5 resulting in a blockade of B-cell differentiation. Here, we show that multimerizati...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
2011
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3197879/ https://ncbi.nlm.nih.gov/pubmed/21765475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.291 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|